Johns Hopkins Fourth Annual Retina Festival 2023
Format: 5 videos + 23 pdfs, size: 6.28 GB
Course Audience: ophthalmologist
Overview:
Date & Location
Saturday, December 2, 2023, 7:00 AM – 5:00 PM, Johns Hopkins School of Medicine, Turner Auditorium, Baltimore, MD
Target Audience
Specialties – Ophthalmology
Overview
The Fourth Annual Retina Festival is an “all-star” line-up of more than 50 faculty members from around the world participating in a Continuing Medical Education event from the Wilmer Eye Institute of the Johns Hopkins University School of Medicine. The program will provide the latest updates from clinical trials and other evidence in the peer-reviewed medical literature that are relevant to the prevention and management of retinal diseases around the world. Topics include the latest, clinically relevant outcomes from clinical trials on age-related macular degeneration, vitreomacular interface abnormalities, hereditary retinal degenerations, diabetic retinopathy, retinal vein occlusions, and the latest in retinal surgery, including live retina surgery demonstrations. In addition to presentations from world experts, 4 panels of experts throughout the day will highlight discussions on applying clinical trial results to day-to-day clinical practice. The course should be of interest to comprehensive ophthalmologists, retina specialists both expert and in training, as well as vision scientists who want an update on the latest clinically relevant topics in retina.
Objectives
- Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
- Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
- Discuss the role of imaging in the management of vitreomacular interface abnormalities.
- Review the current and emerging therapeutic approaches for surgical retinal diseases.
- Summarize the evidence of surgical and medical treatments for intraocular tumors.
- Determine which patients are appropriate for biologic treatments of posterior uveitis.
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
Atropine for Myopia in the Pediatric Population (PDF Format)
Big Data- Benefits and Limitations When Guiding Clinical Practice (PDF Format)
Biosimilar Agents for Neovascular and Other Retinal Diseases (PDF Format)
Current Management of Sickle Cell Retinopathy (PDF Format)
Diabetic Macular Ischemia (PDF Format)
Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management (PDF Format)
Faricimab or Aflibercept HD for Neovascular AMD (PDF Format)
Faricimab or Aflibercept HD in Diabetic Macular Edema (PDF Format)
From Airlie House to ETDRS to DRCR Retina Network in 2022- Imaging NPDR for Risk Factors to Develop PDR (PDF Format)
Gene Therapy for Neovascular AMD (PDF Format)
Geographic Atrophy- Primary Outcome Results from Phase 3 Clinical Trials (PDF Format)
Geographic Atrophy- Secondary and Exploratory Outcome Results from Phase 3 Clinical Trials (PDF Format)
Imaging Choroidal Neovascularization (PDF Format)
Imaging Pathologic Myopia (PDF Format)
Intraocular Tumors (Video MP4 Format)
Keynote Speech- Lessons Learned and Moving Forward with International Collaborations in Retina (PDF Format)
Macular Telangiectasis Treatment Advances (PDF Format)
Other Hot Topics in Retina (Video MP4 Format)
Panel- Clinical Relevance of Geographic Atrophy Clinical Trials (PDF Format)
Pathologic Myopia and Central Serous Retinopathy (Video MP4 Format)
Pediatric and Inherited Retinal Diseases (Video MP4 Format)
Prevention of Diabetic Retinopathy Worsening (PDF Format)
Refillable Drug Delivery Devices in Common Retinal Diseases (PDF Format)
Retinal Gene Therapy in 2024 (PDF Format)
Retinal Vascular Diseases (Video MP4 Format)
Retina_PROGRAM (PDF Format)
The “Not So Silent” Epidemic of Pathologic Myopia (PDF Format)
Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations (PDF Format)
*Detail:
Saturday, December 2, 2023
Welcome and Conference Goals
7:30AM – 7:35AM
Neil Bressler, MD
Keynote Speech: Lessons Learned and Moving Forward with International Collaborations in Retina
7:35AM – 7:45AM
J. Fernando Arevalo, MD, PhD
Age-related Macular Degeneration – Geographic and Other Atrophy- MODERATOR
7:45AM – 8:45AM
Eleonora Lad, MD, PhD
Age-related Macular Degeneration – Geographic and Other Atrophy- MODERATOR
7:45AM – 8:45AM
James Handa, MD
Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management
7:45AM – 7:55AM
Mandeep Singh, MD, PhD
Geographic Atrophy: Primary Outcome Results from Phase 3 Clinical Trials
7:55AM – 8:05AM
Eleonora Lad, MD, PhD
Geographic Atrophy: Secondary and Exploratory Outcome Results from Phase 3 Clinical Trials
8:05AM – 8:15AM
Peter K Kaiser, MD
Preclinical Perspectives to Improve Treatment for Geographic Atrophy
8:15AM – 8:25AM
James Handa, MD
Panel: Clinical Relevance of Geographic Atrophy Clinical Trials
8:25AM – 8:45AM
James Handa, MD
Panel: Clinical Relevance of Geographic Atrophy Clinical Trials
8:25AM – 8:45AM
Mandeep Singh, MD, PhD
Panel: Clinical Relevance of Geographic Atrophy Clinical Trials
8:25AM – 8:45AM
Eleonora Lad, MD, PhD
Panel: Clinical Relevance of Geographic Atrophy Clinical Trials
8:25AM – 8:45AM
Peter K Kaiser, MD
Panel: Clinical Relevance of Geographic Atrophy Clinical Trials -MODERATOR
8:25AM – 8:45AM
Neil Bressler, MD
Age-related Macular Degeneration – Choroidal Neovascularization – MODERATOR
8:45AM – 10:30AM
J. Fernando Arevalo, MD, PhD
Age-related Macular Degeneration – Choroidal Neovascularization – MODERATOR
8:45AM – 10:30AM
Cindy X Cai, MD
Imaging Choroidal Neovascularization
8:45AM – 8:55AM
Voraporn Chaikitmongkol, MD
Gene Therapy for Neovascular AMD
8:55AM – 9:05AM
Peter A Campochiaro, MD
Biosimilar Agents for Neovascular and Other Retinal Diseases
9:05AM – 9:15AM
Sophie J Bakri, MD
Refillable Drug Delivery Devices in Common Retinal Diseases
9:15AM – 9:25AM
Dante Pieramici, MD
Faricimab or Aflibercept HD for Neovascular AMD
9:25AM – 9:35AM
Judy E Kim, MD
Faculty Commentary and Q&A
9:35AM – 10:00AM
Pathologic Myopia and Central Serous Retinopathy -MODERATOR
10:30AM – 11:15AM
Adam S Wenick, MD, PhD
Pathologic Myopia and Central Serous Retinopathy -MODERATOR
10:30AM – 11:15AM
Kyoko Ohno-Matsui, MD
The “Not So Silent” Epidemic of Pathologic Myopia
10:30AM – 10:40AM
Tien Y Wong, MD, PhD
Imaging Pathologic Myopia
10:40AM – 10:50AM
Kyoko Ohno-Matsui, MD
Recent Insights into Central Serous Retinopathy
10:50AM – 11:00AM
Faculty Commentary and Q&A
11:00AM – 11:15AM
Choroidal Melanoma Management in 2024
11:15AM – 11:25AM
Carol L Shields, MD
Intraocular Tumors -MODERATOR
11:15AM – 12:45PM
Carol L Shields, MD
Intraocular Tumors -MODERATOR
11:15AM – 12:45PM
David H Abramson, MD
Retinoblastoma Management in 2024
11:25AM – 11:35AM
David H Abramson, MD
Faculty Commentary and Q&A
11:35AM – 11:45AM
Pediatric and Inherited Retinal Diseases -MODERATOR
12:45PM – 1:45PM
Joseph Anaya, MD, MBA
Pediatric and Inherited Retinal Diseases -MODERATOR
12:45PM – 1:45PM
Ishrat Ahmed, MD, PhD
Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations
12:45PM – 12:55PM
William F Mieler, MD
Atropine for Myopia in the Pediatric Population
12:55PM – 1:05PM
Michael Repka, MD, MBA
Retinal Gene Therapy in 2024
1:05PM – 1:15PM
Byron L Lam, MD
Managing ROP in 2024
1:15PM – 1:25PM
Yoshihiro Yonekawa, MD
Faculty Commentary and Q&A
1:25PM – 1:45PM
Diabetic Macular Ischemia
1:45PM – 1:55PM
Sobha Sivaprasad, MD
Retinal Vascular Diseases -MODERATOR
1:45PM – 3:00PM
Adrienne Scott, MD
Retinal Vascular Diseases -MODERATOR
1:45PM – 3:00PM
Jennifer I Lim, MD
Macular Telangiectasis Treatment Advances
1:55PM – 2:05PM
Emily Chew, MD
Current Management of Sickle Cell Retinopathy
2:05PM – 2:15PM
Jennifer I Lim, MD
Faculty Commentary and Q&A
2:15PM – 2:30PM
Diabetic Retinopathy – MODERATOR
3:00PM – 3:45PM
Jun Kong, MD, PhD
Diabetic Retinopathy – MODERATOR
3:00PM – 3:45PM
Sophie Cai, MD
Prevention of Diabetic Retinopathy Worsening
3:00PM – 3:10PM
Raj Maturi, MD
From Airlie House to ETDRS to DRCR Retina Network in 2022: Imaging NPDR for Risk Factors to Develop PDR
3:10PM – 3:20PM
Jennifer Sun, MD, MPH
Faricimab or Aflibercept HD in Diabetic Macular Edema
3:20PM – 3:30PM
Christina Y. Weng, MD, MBA
Faculty Commentary and Q&A
3:30PM – 3:45PM
Other Hot Topics in Retina – MODERATOR
3:45PM – 5:30PM
Mira Sachdeva, MD, PhD
Other Hot Topics in Retina – MODERATOR
3:45PM – 5:25PM
Elia Duh, MD
Recent Advances and Challenges with Artificial Intelligence in Retina
3:45PM – 3:55PM
Jun Kong, MD, PhD
Big Data: Benefits and Limitations When Guiding Clinical Practice
3:55PM – 4:05PM
Cindy X Cai, MD
Equity, Diversity, and Inclusiveness in Retina
4:05PM – 4:15PM
Adrienne Scott, MD
Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management
4:15PM – 4:25PM
Mandeep Singh, MD, PhD
Faculty Commentary and Q&A -MODERATOR
4:25PM – 4:55PM
Mira Sachdeva, MD, PhD
Faculty Commentary and Q&A -MODERATOR
4:25PM – 4:55PM
Elia Duh, MD